GSK To Maintain Avandia Sales Rep Totals After Bristol Copromotion Ends

GlaxoSmithKline will continue to support the anti-diabetic Avandia with 2000 sales reps after a copromotion agreement with Bristol-Myers Squibb ends Aug. 20